The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Selective Cell and Network Vulnerability in Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed)
The goal of this FOA is to define and characterize neural cell populations, neural circuits, and brain networks and regions that are vulnerable to brain aging and Alzheimer's disease (AD). Understanding mechanisms underlying selective vulnerability from cells to networks in AD is critical to fully define the disease process and to develop effective therapies.
- Letter of Intent Due Date(s): 30 days before the application due date
- R01 Due Dates: Feb. 5, Jun. 5, Oct. 5
PAR-18-706 Expiration Date November 6, 2019